Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Shares, par value (euro) 0.12 per share
-
Shares outstanding
-
22.4M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
11.5M
-
Shares change
-
+3.62M
-
Total reported value, excl. options
-
$62.5M
-
Value change
-
+$21.4M
-
Put/Call ratio
-
0.44
-
Number of buys
-
49
-
Number of sells
-
-41
-
Price
-
$5.43
Significant Holders of CureVac N.V. - Common Shares, par value (euro) 0.12 per share (CVAC) as of Q2 2025
109 filings reported holding CVAC - CureVac N.V. - Common Shares, par value (euro) 0.12 per share as of Q2 2025.
CureVac N.V. - Common Shares, par value (euro) 0.12 per share (CVAC) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.5M shares
of 22.4M outstanding shares and own 51.37% of the company stock.
Largest 10 shareholders include ALPINE ASSOCIATES MANAGEMENT INC. (1.97M shares), Qube Research & Technologies Ltd (1.18M shares), BlackRock, Inc. (1.03M shares), WATER ISLAND CAPITAL LLC (957K shares), GLAZER CAPITAL, LLC (595K shares), GOLDMAN SACHS GROUP INC (434K shares), NORTHERN TRUST CORP (392K shares), JPMORGAN CHASE & CO (314K shares), Quinn Opportunity Partners LLC (271K shares), and NATIONAL BANK OF CANADA /FI/ (259K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.